Candesartan may offer neurocognitive protection against mild cognitive impairment
23 Sep 2020
byAudrey Abella
The ARB* candesartan was superior to the ACEi** lisinopril in improving neurocognitive function in older hypertensive adults with mild cognitive impairment (MCI), a study has shown.
Candesartan may offer neurocognitive protection against mild cognitive impairment
23 Sep 2020